1. Home
  2. Browse
  3. Hospital Practice
  4. Hematology & Oncology

Hematology & Oncology

31 - 45 of 47 Results
Sort Results:
Commentary: Changes to the REMS Requirements for Erythropoiesis-Stimulating Agents (ESA) June 2017
Article: Be Aware of Changes in the Erythropoiesis-Stimulating Agent REMS Program June 2017
Article: Help Optimize Peri-Op Antifibrinolytic Use to Reduce Blood Transfusions April 2017
Chart: Reducing Perioperative Blood Transfusions April 2017
Chart: Treatment of Febrile Neutropenia in Adults: Pharmacotherapy Overview September 2016
Article: Don't Automatically Start Empiric Vancomycin for Febrile Neutropenia September 2016
Article: Don't Use Obizur for Congenital Hemophilia A February 2015
Other: Oral Oncology Drugs: Addressing the Challenges January 2015
Article: Use Teach Back To Verify Oral Chemo Regimens January 2015
Commentary: Zofran (Ondansetron) and QT Prolongation: An Update September 2012
Chart: Comparison of IVIG Products November 2011
Commentary: Dose Conversions for Epoetin and Darbepoetin December 2010
Commentary: ESA APPRISE Oncology Program for Cancer Patients Using Procrit, Epogen, or Aranesp April 2010
Commentary: “Off-Label” Uses of Ondansetron January 2008
Guideline: CDC Recommendations for Managing Acute Gastroenteritis Among Children (2003) January 2008